| Regulating Pair |
| Introduced Variation |
Inhibition (Unlabeled Para-aminohippurate (PAH)) of SLC22A6 |
Protein Info
|
| Induced Change |
4-Aminohippuric acid concentration: decrease |
Metabo Info
|
| Summary |
Introduced Variation
Induced Change
|
|
|
|
|
|
|
|
| Full List of Experiment(s) Validating This Regulating Pair |
| Details of Experiment for Validating This Pair |
[1] |
| Method |
Quantifying the change of 4-aminohippuric acid concentration after SLC22A6 inhibition through kit detection. |
| Disease Status |
Healthy individual |
| Organ/Tissue/Cell Line |
Xenopus laevis oocytes |
N.A. |
| Subcellular Location |
Membrane (Cell membrane) |
| Tested Species |
Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
|
| Details |
It is reported that inhibition of SLC22A6 leads to the decrease of 4-aminohippuric acid levels compared with control group in xenopus laevis oocytes. |
|
|
|
|
|
|
|
| References |
| 1 |
Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther. 2005 May;313(2):621-8.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
